Dennis Matheis has bought stock on 4 days since May 2025

Dennis Matheis is a healthcare industry executive and corporate insider who serves as a Director at Lucid Diagnostics Inc. (Nasdaq: LUCD), where he has been a member of the Board of Directors since May 6, 2024.( In this role, he contributes more than three decades of leadership experience in healthcare delivery and health insurance to the company’s mission of developing and commercializing diagnostics for the early detection of esophageal precancer and cancer.( As an insider at Lucid Diagnostics, he has been an active purchaser of company stock, including multiple open-market acquisitions that have significantly increased his direct ownership stake.(

Matheis is President and Chief Executive Officer of Sentara Health, a Virginia-based, not-for-profit integrated health system that ranks among the twenty largest in the United States, with nearly $13 billion in annual revenue and more than 32,000 employees.( Before becoming CEO, he served as Executive Vice President of Sentara Healthcare and President of Sentara Health Plans, where he led the largest health plan acquisition in Sentara’s history, adding more than 400,000 members and nearly 1,300 employees.( Earlier in his career, he spent 13 years in leadership roles at Anthem, Inc., including serving as President of Anthem’s Central Region and Exchanges, and previously held senior roles at Anthem Blue Cross and Blue Shield of Missouri, CIGNA Healthcare, Humana Health Plan, and Advocate Health Care in Chicago.( Matheis holds a Bachelor of Science in Accounting from the University of Kentucky and practiced as a Certified Public Accountant before entering the healthcare industry; he also serves on multiple boards, including Lucid Diagnostics, DarioHealth, the Virginia Foundation for Independent Colleges, and the Executive Committee of America’s Health Insurance Plans (AHIP).(

Written by Perplexity from public sources.